Skip to main content
. 2019 Jul 19;181(3):363–374. doi: 10.1530/EJE-19-0291

Table 3.

HLA genotype in patients with ICI-induced diabetes.

HLA genotype Serotype #
Susceptible 31/51 (61%) A2.1 5
Susceptible and protective 2/51 (4%) DR3 8
Neutral 10/51 (20%) DR4 23
Protective 8/51 (16%) DR9 5
N/A 40/91 DR4-DQ4 2
Other 15

ICI, immune checkpoint inhibitor; N/A, not available.